Genmab — November 2020
-
yes, maybe. but i don't expect new data @AaBforever , more of a deep dive into what we know and more explanation
-
Nordea think the liver side-effects may hinder going to high doses!
-
@Mogan, jeg er knap 100% kontant, solgte ud før præsidentvalget i US. Har ikke haft Genmab nogle måneder og venter på godt entrypoint. Tror vi skal længere ned i hele markedet , 2150 er bare et fiktivt tal, men i det område køber jeg gerne igen. Tror meget stærkt på Genmab på den lange bane.
-
Aktier: USA-frygtindeks ligger højt, men langt fra corona-tophttps://www.proinvestor.com/investornyt/669481/aktier-usa-frygtindeks-ligger-hojt-men-langt-fra-corona-top
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind